Answers are grounded in this paper and cite their sources.
Targeted drug delivery is usually framed as a problem of increasing affinity for a desired tissue or cell. That framing is incomplete because an administered carrier is simultaneously exposed to biological compartments that remove, retain, transform, redistribute, or consume it before and after target contact. These competing sinks include the mononuclear phagocyte system, liver and spleen, renal and pulmonary pathways, adsorbed proteins, nontarget cellular populations, and finite receptor pools
No takes yet. Share an insight, caveat, or question.
Fedorova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: